Hims & Hers Health (NYSE:HIMS) Shares Gap Down - Time to Sell?

Hims & Hers Health, Inc. (NYSE:HIMS - Get Free Report) gapped down prior to trading on Friday . The stock had previously closed at $25.73, but opened at $24.15. Hims & Hers Health shares last traded at $25.01, with a volume of 2,507,628 shares.

Analyst Upgrades and Downgrades

HIMS has been the subject of several analyst reports. Deutsche Bank Aktiengesellschaft raised their price target on shares of Hims & Hers Health from $23.00 to $27.00 and gave the company a "hold" rating in a report on Wednesday, November 6th. Canaccord Genuity Group boosted their target price on Hims & Hers Health from $28.00 to $38.00 and gave the stock a "buy" rating in a research report on Monday, December 2nd. TD Cowen restated a "buy" rating and issued a $28.00 target price on shares of Hims & Hers Health in a research note on Wednesday, November 20th. Needham & Company LLC lifted their price target on Hims & Hers Health from $28.00 to $31.00 and gave the company a "buy" rating in a research report on Monday. Finally, Morgan Stanley assumed coverage on shares of Hims & Hers Health in a research report on Tuesday, December 17th. They issued an "overweight" rating and a $42.00 price objective on the stock. Two research analysts have rated the stock with a sell rating, seven have assigned a hold rating and eight have given a buy rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Hold" and a consensus target price of $25.13.

Hims & Hers Health Stock Down 1.2 %

The firm's 50-day simple moving average is $27.21 and its 200-day simple moving average is $21.65. The firm has a market capitalization of $5.55 billion, a PE ratio of 57.75 and a beta of 1.31.

Hims & Hers Health (NYSE:HIMS - Get Free Report) last issued its earnings results on Monday, November 4th. The company reported $0.32 earnings per share for the quarter, beating the consensus estimate of $0.06 by $0.26. The company had revenue of $401.56 million during the quarter, compared to analysts' expectations of $382.20 million. Hims & Hers Health had a return on equity of 10.97% and a net margin of 8.19%. Hims & Hers Health's quarterly revenue was up 77.1% compared to the same quarter last year. During the same period in the prior year, the business posted ($0.04) EPS. On average, equities research analysts forecast that Hims & Hers Health, Inc. will post 0.29 earnings per share for the current year.

Insider Buying and Selling at Hims & Hers Health

In related news, insider Soleil Boughton sold 2,339 shares of Hims & Hers Health stock in a transaction on Tuesday, October 15th. The shares were sold at an average price of $20.41, for a total value of $47,738.99. Following the sale, the insider now owns 172,274 shares in the company, valued at $3,516,112.34. The trade was a 1.34 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Patrick Harrison Carroll sold 15,000 shares of the company's stock in a transaction on Wednesday, November 6th. The stock was sold at an average price of $22.07, for a total transaction of $331,050.00. Following the completion of the transaction, the insider now owns 196,941 shares of the company's stock, valued at $4,346,487.87. This trade represents a 7.08 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 1,333,446 shares of company stock worth $34,175,197. 17.71% of the stock is currently owned by company insiders.

Institutional Trading of Hims & Hers Health

Several large investors have recently bought and sold shares of HIMS. Renaissance Technologies LLC increased its stake in shares of Hims & Hers Health by 113.1% in the 2nd quarter. Renaissance Technologies LLC now owns 6,039,408 shares of the company's stock worth $121,936,000 after acquiring an additional 3,205,108 shares in the last quarter. Wellington Management Group LLP increased its stake in shares of Hims & Hers Health by 34.5% during the third quarter. Wellington Management Group LLP now owns 3,444,414 shares of the company's stock valued at $63,446,000 after purchasing an additional 883,230 shares in the last quarter. Geode Capital Management LLC lifted its holdings in shares of Hims & Hers Health by 12.7% during the third quarter. Geode Capital Management LLC now owns 4,289,549 shares of the company's stock valued at $79,029,000 after purchasing an additional 482,177 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund boosted its position in shares of Hims & Hers Health by 164.1% in the 2nd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 528,142 shares of the company's stock worth $10,663,000 after purchasing an additional 328,142 shares in the last quarter. Finally, Carnegie Investment Counsel bought a new stake in shares of Hims & Hers Health in the 3rd quarter worth approximately $5,531,000. 63.52% of the stock is owned by institutional investors.

About Hims & Hers Health

Hims & Hers Health, Inc operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers.